Dashboard
Manage Tickers

SWTXSpringWorks Therapeutics, Inc.

Nasdaq springworkstx.com


$ 41.41 $ 0.08 (0.19 %)    

Friday, 12-Jul-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 494.79 $ 2.89 (0.59 %)
DIA $ 400.37 $ 2.69 (0.68 %)
SPY $ 559.91 $ 3.51 (0.63 %)
TLT $ 93.88 $ 0.40 (0.43 %)
GLD $ 223.10 $ -0.14 (-0.06 %)
$ 41.44
$ 41.97
$ 41.42 x 300
$ 0.00 x 0
$ 41.05 - $ 42.66
$ 18.00 - $ 53.92
664,180
na
3.06B
$ 0.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

springworks-therapeutics-has-completed-the-submission-of-a-new-drug-application-to-the-fda-for-mirdametinib-for-pediatric-and-adult-patients-with-neurofibromatosis-type-1--associated-plexiform-neurofibromas
SpringWorks Therapeutics Has Completed The...
07/01/2024 10:32:15

In the second half of 2024, SpringWorks also plans to file a Marketing Authorization Application (MAA) with the European Medici...

Core News & Articles
SpringWorks Therapeutics Inc Says Terminat...
06/07/2024 20:27:06

- SEC Filing

Core News & Articles
SpringWorks Therapeutics Says Termination ...
06/07/2024 20:26:22

- SEC Filing

Core News & Articles
SpringWorks Therapeutics Says Deal Termina...
06/07/2024 20:25:37

- SEC Filing

Core News & Articles
SpringWorks Therapeutics Got Notice Of Ter...
06/07/2024 20:24:07

- SEC Filing

hc-wainwright--co-reiterates-buy-on-springworks-therapeutics-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on Spri...
06/04/2024 10:48:49

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

hc-wainwright--co-reiterates-buy-on-springworks-therapeutics-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on Spri...
05/31/2024 10:16:18

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

hc-wainwright--co-reiterates-buy-on-springworks-therapeutics-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on Spri...
05/06/2024 10:35:24

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

springworks-cash-cash-equivalents-and-marketable-securities-were-573m-as-of-march-31-2024
Springworks' Cash, Cash Equivalents And Ma...
05/02/2024 10:35:37

springworks-therapeutics-q1-2024-gaap-eps-118-misses-116-estimate-sales-21006m-beat-12206m-estimate
SpringWorks Therapeutics Q1 2024 GAAP EPS ...
05/02/2024 10:32:52

SpringWorks Therapeutics (NASDAQ:SWTX) reported quarterly losses of $(1.18) per share which missed the analyst consensus estima...

hc-wainwright--co-maintains-buy-on-springworks-therapeutics-raises-price-target-to-74
HC Wainwright & Co. Maintains Buy on Sprin...
03/06/2024 13:30:20

HC Wainwright & Co. analyst Robert Burns maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and raises the pric...

jp-morgan-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-74
JP Morgan Maintains Overweight on SpringWo...
03/06/2024 11:38:41

JP Morgan analyst Anupam Rama maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

springworks-therapeutics-has-initiated-a-rolling-submission-of-a-new-drug-application-to-fda-for-mirdametinib-in-pediatric-and-adult-patients-with-neurofibromatosis-type-1-associated-plexiform-neurofibromas-expected-to-complete-by-q2-of-2024
SpringWorks Therapeutics Has Initiated A R...
03/04/2024 11:37:23

springworks-therapeutics-announces-european-medicines-agency-validation-for-marketing-authorization-application-of-nirogacestat-for-treatment-of-adults-with-desmoid-tumors
SpringWorks Therapeutics Announces Europea...
02/29/2024 14:02:12

barclays-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-63
Barclays Maintains Overweight on SpringWor...
02/29/2024 13:26:58

Barclays analyst Peter Lawson maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

springworks-therapeutics-q4-earnings-insights
SpringWorks Therapeutics: Q4 Earnings Insi...
02/27/2024 14:00:13

springworks-therapeutics-reported-q4-ogsiveo-net-product-revenues-of-54m-eps-loss-of-144-vs-119-yoy-cash-of-6626m
SpringWorks Therapeutics Reported Q4 OGSIV...
02/27/2024 11:39:24

wedbush-maintains-outperform-on-springworks-therapeutics-raises-price-target-to-70
Wedbush Maintains Outperform on SpringWork...
02/26/2024 14:44:33

Wedbush analyst David Nierengarten maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Outperform and raises the price t...

watching-springworks-therapeutics-traders-circulate-unconfirmed-note-suggesting-company-seeing-takeover-interest
Watching SpringWorks Therapeutics; Traders...
02/16/2024 16:48:05

barclays-maintains-overweight-on-springworks-therapeutics-raises-price-target-to-47
Barclays Maintains Overweight on SpringWor...
01/25/2024 14:56:46

Barclays analyst Peter Lawson maintains SpringWorks Therapeutics (NASDAQ:SWTX) with a Overweight and raises the price target...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)